JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2007; 50:1561-1569, doi:10.1016/j.jacc.2007.07.016 (Published online 1 October 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.07.016v1
50/16/1561    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandek, A.
Right arrow Articles by Anker, S. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sandek, A.
Right arrow Articles by Anker, S. D.

CLINICAL RESEARCH

Altered Intestinal Function in Patients With Chronic Heart Failure

Anja Sandek, MD{dagger}, Juergen Bauditz, MD{dagger}, Alexander Swidsinski, MD{dagger}, Sabine Buhner, PhD{dagger}, Jutta Weber-Eibel, MD{dagger}, Stephan von Haehling, MD{ddagger}, Wieland Schroedl§, Tim Karhausen*, Wolfram Doehner, MD, PhD*, Mathias Rauchhaus, MD, PhD*, Philip Poole-Wilson, MD, FMedSci,{ddagger}, Hans-Dieter Volk, MD, PhD,||, Herbert Lochs, MD, PhD,{dagger} and Stefan D. Anker, MD, PhD*,{ddagger},*

* Division of Applied Cachexia Research, Department of Cardiology, Charite, Campus Virchow-Klinikum, Berlin, Germany
{dagger} Department of Gastroenterology, Charite, Campus Mitte, Berlin, Germany
{ddagger} Department of Clinical Cardiology, National Heart & Lung Institute, Imperial College London, London, United Kingdom
§ Institute of Bacteriology and Mycology, Veterinary Faculty, Leipzig, Germany
|| Department of Medical Immunology, Charite, Campus Mitte, Berlin, Germany

Manuscript received October 23, 2006; revised manuscript received June 26, 2007, accepted July 17, 2007.

* Reprint requests and correspondence: Prof. Stefan D. Anker, Division of Applied Cachexia Research, Department of Cardiology, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, D-13353 Berlin, Germany. (Email: s.anker{at}cachexia.de).

Objectives: We evaluated morphology and function of the gut in patients with chronic heart failure (CHF).

Background: Intestinal translocation of bacterial endotoxin may contribute to the inflammatory state observed in patients with CHF. The morphology and function of the gut may be abnormal.

Methods: We studied 22 patients with CHF (age 67 ± 2 years, left ventricular ejection fraction [LVEF] 31 ± 1%, New York Heart Association functional class 2.3 ± 0.1, peak VO 2 15.0 ± 1.0 ml/kg/min) and 22 control subjects (62 ± 1 years, LVEF 68 ± 2%, peak VO 2 24.7 ± 1.3 ml/kg/min). Bowel wall thickness was assessed by transcutaneous sonography, small intestinal permeability by the lactulose-mannitol test, passive carrier-mediated transport by D-xylose test, large intestinal permeability by sucralose test (5- and 26-h urine collection, high-performance liquid chromatography), and mucosal bacterial biofilm by fluorescence in situ hybridization in biopsies taken during sigmoidoscopy.

Results: Chronic heart failure patients, compared with control patients, showed increased bowel wall thickness in the terminal ileum (1.48 ± 0.16 mm vs. 1.04 ± 0.08 mm), ascending colon (2.32 ± 0.18 mm vs. 1.31 ± 0.14 mm), transverse colon (2.19 ± 0.20 vs. 1.27 ± 0.08 mm), descending colon (2.59 ± 0.18 mm vs. 1.43 ± 0.13 mm), and sigmoid (2.97 ± 0.27 mm vs. 1.64 ± 0.14 mm) (all p < 0.01). Chronic heart failure patients had a 35% increase of small intestinal permeability (lactulose/mannitol ratio: 0.023 ± 0.001 vs. 0.017 ± 0.001, p = 0.006), a 210% increase of large intestinal permeability (sucralose excretion: 0.62 ± 0.17% vs. 0.20 ± 0.06%, p = 0.03), and a 29% decrease of D-xylose absorption, indicating bowel ischemia (26.7 ± 3.0% vs. 37.4 ± 1.4%, p = 0.003). Higher concentrations of adherent bacteria were found within mucus of CHF patients compared with control subjects (p = 0.007).

Conclusions: Chronic heart failure is a multisystem disorder in which intestinal morphology, permeability, and absorption are modified. Increased intestinal permeability and an augmented bacterial biofilm may contribute to the origin of both chronic inflammation and malnutrition.

Abbreviations and Acronyms
  CHF = chronic heart failure
  ELISA = enzyme-linked immunosorbent assay
  FISH = fluorescence in situ hybridization
  hs CrP = high-sensitivity C-reactive protein
  IL = interleukin
  LPS = lipopolysaccharide
  LVEF = left ventricular ejection fraction
  NYHA = New York Heart Association
  PI = permeability index
  TNF = tumor necrosis factor
  VO2 = oxygen consumption







HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.